Published on 6 March 2023
Description:
Welcome to the March 2023 issue of Pharmafocus! This issue covers the latest pharma news, and features articles on CVD, supply chains and the importance of the patient voice.
45 articles from this collection:
NICE Recommends More Digital Mental Health Therapies For NHS Use
NICE has recommended eight new digital therapies to be used by the NHS for the treatment of mental health disorders
Pharmafile
introducing our new digital edition website
iNtRON Confirms Efficacy Of ‘Inhalation Anthrax’-fighting Drug
iNtRON has announced the completion of an efficacy evaluation study of BAL200
25 Communique Awards 2023
Now open for entry
Contents
This issue includes the hottest news as well as some fascinating articles from CVD awareness to stabilising the supply chain
Comment
Pharmafocus' editor introduces this issue, mentioning this month's biggest news and the articles included in the edition
Samedan Ltd
Fast, effective insight - www.samedanltd.com
Cambridge’s Experimental Cancer Medicine Centre To Receive Funding
The ECMC in Cambridge is one of a handful of organisations to receive a share of £47.5 funding over the next five years
Eli Lilly And AbbVie Leave UK VPAS; Blow To UK Pharma Industry
Eli Lilly and AbbVie both announce that they will leave VPAS, causing concern that NHS patients may not receive breakthrough drug treatments
Merck’s London Research Hub To Begin Construction In April 2023
Merck has been planning a $1.3bn research hub in london for the last six years, but this will finally begin construction in April
NHS To Offer Artificial Pancreas To Type 1 Diabetes Patients
The NHS will soon begin offering artificial pancreas to type 1 diabetes patients to help them manage their condition more effectively
Scottish Biotech Aims To Cure Common Cold
ScotBio has announced "promising initial results" from its attempt to extract a cure for the common cold from algae
UCL To Begin New Trial To Assess Cough Medicine’s Impact On Parkinson’s Disease
Researchers at UCL have begun looking into the impacts of ambroxol as a treatment for Parkinson's disease
AstraZeneca Moves Manufacturing To Ireland Due To Britain’s Tax Regime
AstraZeneca has announced plans to open a new facility in Ireland, previously planned for northwest England
Europe Plans Further Antibiotic Shortage Countermeasures
Following the increase in respiratory infections, the continuing cost of living crisis and the Russia-Ukraine conflict, Europe is planning countermeasures for further antibiotic shortages
Genoscience Pharma Received Orphan Drug Designation For Hepatocellular Carcinoma Drug
Genoscience Pharma has received FDA ODD for its hepatocellular carcinoma drug
Australia’s TGA Approves Psychedelics To Treat Mental Health Conditions
The TGA has announced its approval of the use of psychedelics to treat certain mental health conditions
Drug-resistant Bacterium Found In Eye Drops Has Infected 55 People In 12 States
A strongly drug-resistant bacterium has been found in various brands of artificial tears eye drops, infecting 55 people throughout 12 states
First Indian Intranasal COVID-19 Vaccine Recently Launched
Bharat Biotech has recently launched its new intranasal COVID-19 vaccine iNCOVACC
Johnson & Johnson Subsidiary Loses US Bankruptcy Bid
A subsidiary of J&J has lost a bankruptcy petition aiming to transfer thousands of legal claims against the subsidiary related to the claim that its talcum powder causes cancer
Stand Up To Cancer Announces Four Teams Dedicated To Increasing Diversity In Clinical Trials
SU2C has announced four teams focusing on increasing diversity in early phase cancer clinical trials
WHO Issues A ‘Call To Action’ After Cough Syrup Deaths
WHO has issued a 'call to action' to all member states in order to try to prevent, detect and respond to incidences of illegitimate medical products
TheracosBio’s Oral Drug Approved By FDA For Adults With Type 2 Diabetes
TheracosBio has announced that bexaglifozin has been approved by the FDA for the treatment of adult patients with type 2 diabetes, despite originally being indicated for cats with diabetes
Johnson & Johnson’s Ethicon Undertakes First Robot-assisted Kidney Stone Removal
J&J's Ethicon has announced that it has undertaken its first robot-assisted kidney stone removal using its Monarch Platform
SynaptixBio Secures FDA Rare Paediatric Disease Designation To Develop Treatments For Leukodystrophy
SynaptixBio has received FDA Rare Paediatric Disease designation to develop new treatments for rare disease TUBB4a leukodystropy
AbbVie Expects 37% Decline In Humira Sales Following New Biosimilars Hitting The US Market
AbbVie has announced that it expects a 37% decline in sales of Humira following the approval of biosimilars
Boston Scientific Fined $42m Over Patent Infringement
Following a five-year legal battle between Boston Scientific and TissueGen, Boston Scientific has had to pay $42m
Garuda Therapeutics Closes Series B Funding With $62m
Garuda Therapeutics has announced that it has closed series B funding with $62m
Daiichi Sankyo To Build Japan’s First Factory For mRNA COVID-19 Vaccines
Daiichi Sankyo shares plans to build its first mRNA COVID-19 vaccine factory in Japan
Eli Lilly Plans To Invest $450m At Production Site In Research Triangle Park
Eli Lilly has announced plans to invest $450m in manufacturing facilities at Research Triangle Park in North Carolina, US
Johnson & Johnson Scale Back COVID-19 Vaccination Production
J&J has begun scaling back its COVID-19 vaccine producation due to the falling demand for the jabs
AI Finds Liver Cancer Drug Candidate In Only 30 Days
A team of scientists have broken records with their new AI which has found a novel drug candidate for liver cancer in only 30 days
BD Showcases New-generation Robotic Track System For Microbiology Labs
Becton, Dickinson and Company has revealed its new-generation robotic track system
DrugBAN AI Expected To Reduce Costs And Speed Up Drug Discovery
A new AI has been developed to deliver medicines at a faster rate and lower cost
Pharmatimes
Be part of the 2023 Clinical Researcher of the Year - The Americas!
Improving Cardiovascular Disease Care And Awareness
Pharmafocus talks to Scott Curley about the risks of CVD and the imporance of getting the right treatment at the right time
The Patient Voice In Autoimmune Conditions
Rhian Linney, Associate Communications Director at Galapagos, UK and Ireland, tells Pharmafocus about the significance of the patient voice in autoimmune conditions, focusing on rehumatoid arthritis
Removing Uncertainty In The Supply Chain
Nikunj Desai, head of supply chain at ACG, explores how supply chains can be made more secure and the impacts this may have on the pharma industry
Samedan
Introducing the new Innovations in Pharmaceutical Technology website www.iptonline.com
Chiesi Farmaceutici Hires New CEO After $1.48bn Amryt Acquisition
Giuseppe Accogli is hired as Chiesi Farmaceutici's new CEO
Ingenza Appoints Dr Mark Chadwick As Strategic Business Advisor
Dr Mark Chadwick is appointed to Ingenza's strategic business advisor
Medivir Ab Appoints Pia Baumann As Chief Medical Officer
Pia Baumann is appointed to Medivir AB's chief medical officer
Vishal Kapoor Appointed To Jasper Therapeutics’ Board Of Directors
Vishal Kapoor joins Jasper Therapeutics' board of directors
Five Facts About Cardiovascular Disease (CVD)
Pharmafocus shares five interesting facts about CVD
PharmaTimes
The 2023 International Clinical Researcher of the Year - entry deadline is approaching
Pharmafocus
Pharmaceutical Industry news, analysis and insights